A large body of evidence shows that there is a change in the density of cortical serotonin2A receptors (5HT2AR) in post-mortem CNS from subjects with schizophrenia. Furthermore, some antipsychotic drugs have also been shown to cause a decrease in the density of 5HT2AR in the rat CNS. Thus, it appeared possible that changes in this receptor in human post-mortem CNS simply reflected an antipsychotic drug effect. However, a great deal of research on the 5HT2AR and schizophrenia now suggests that the changes in this receptor are complex and may be involved in both the pathology of the disorder and the effects of some antipsychotic drugs. Moreover, recent advances in basic research on the role of the 5HT2AR in the CNS add further support to the hypothesis that the receptor could be involved in the pathology of the illness. In particular, an argument will be developed that the changes in the 5HT2AR in schizophrenia are reflective of a real or perceived change in serotonergic tone and that this forms an important part of the pathology of the illness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1046/j.1471-4159.2003.01693.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serotonin syndrome caused by escitalopram in Parkinson's disease psychosis: a case report.
BMC Geriatr
September 2024
Affiliated Mental Health Center of Jiangnan University, No. 156 QianRong Rd, Wuxi, Jiangsu, 214151, China.
Article Synopsis
- Serotonin syndrome and Parkinson's disease have overlapping symptoms, making accurate diagnosis critical for appropriate treatment, as misdiagnosis can lead to severe complications.
- A case study of a 75-year-old woman revealed serotonin syndrome triggered by escitalopram, initially mistaken for worsened Parkinson's symptoms, highlighting the importance of therapeutic drug monitoring.
- The findings emphasize the need for healthcare providers to distinguish between serotonin syndrome and Parkinson's manifestations to ensure proper treatment and management, particularly in patients with psychiatric conditions linked to Parkinson's disease.
The Hallucinogenic Serotonin Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex.
Front Mol Neurosci
December 2021
Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai, India.
Psychedelic compounds that target the 5-HT receptor are reported to evoke psychoplastogenic effects, including enhanced dendritic arborization and synaptogenesis. Transcriptional regulation of neuronal plasticity-associated genes is implicated in the cytoarchitectural effects of serotonergic psychedelics, however, the transcription factors that drive this regulation are poorly elucidated. Here, we addressed the contribution of the transcription factor cyclic adenosine monophosphate (cAMP)-response element binding protein (CREB) in the regulation of neuronal plasticity-associated genes by the hallucinogenic 5-HT receptor agonist, 2,5-dimethoxy-4-iodoamphetamine (DOI).
View Article and Find Full Text PDFTranscriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD.
Elife
July 2021
Department of Psychiatry, Yale University, New Haven, United States.
Psychoactive drugs can transiently perturb brain physiology while preserving brain structure. The role of physiological state in shaping neural function can therefore be investigated through neuroimaging of pharmacologically induced effects. Previously, using pharmacological neuroimaging, we found that neural and experiential effects of lysergic acid diethylamide (LSD) are attributable to agonism of the serotonin-2A receptor (Preller et al.
View Article and Find Full Text PDFMeasurement of changes in endogenous serotonin level by positron emission tomography with [F]altanserin.
Ann Nucl Med
August 2021
Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institute for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Objective: Positron emission tomography (PET) has been used to investigate changes in the concentration of endogenous neurotransmitters. Recently, this technique has been applied to the imaging of serotonin receptors using [F]altanserin. In these measurements, a reduction in binding potential (BP) suggests an increase in endogenous serotonin levels caused by pharmacological or cognitive stimulations, and the sensitivity of BP reduction depends on the characteristics of [F]altanserin.
View Article and Find Full Text PDF5-HT receptor-mediated Gα activation in psychiatric disorders: A postmortem study.
World J Biol Psychiatry
September 2021
Laboratory of Neuropharmacology, IUNICS/IdISPa, University of the Balearic Islands (UIB), Palma de Mallorca, Spain.
Objectives: Serotonin-2A (5-HT) receptors play an important role in the regulation of many brain functions that are disturbed in patients with such psychiatric diseases as mood disorders and schizophrenia. The objective of this study was to evaluate 5-HT receptor-mediated signalling pathway through Gα activation in psychiatric patients by using post-mortem brain samples.
Methods: Functional activation of Gα proteins coupled to 5-HT receptors was determined by means of [S]GTPγS binding/immunoprecipitation assay in post-mortem prefrontal cortex of psychiatric patients diagnosed as bipolar disorder (BP), major depressive disorder (MDD), and schizophrenia, and individually matched controls.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!